Excipients are inactive substances that are added to oral solid dosage forms to aid in the manufacturing process, improve the stability, and enhance the performance of the active pharmaceutical ingredients (APIs). Excipients can include fillers, binders, disintegrants, lubricants, and coatings, among others. Excipients play a crucial role in the development and manufacturing of oral solid dosage forms, ensuring the quality, safety, and efficacy of the final product. The selection and use of appropriate excipients are essential to achieve the desired product characteristics and meet regulatory requirements. According to the latest estimates, the global excipients for oral solid dosage forms market is set to achieve an incremental growth of USD 1.7 billion, accelerating at a CAGR of almost 5.3% during the forecast period 2023-2029.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on excipients for oral solid dosage forms can be segmented by product: binders and fillers, coatings, disintegrants, lubricants, sweetening agent, others. The binders and fillers segment captured the largest share of the market in 2022. Excipients for oral solid dosage forms market is further segmented by region: North America, Europe, Asia-Pacific, Rest of the World (RoW). North America held the largest share of the global excipients for oral solid dosage forms market in 2022 and is anticipated to hold its share during the forecast period.

The binders and fillers market is further segmented into lactose, methylcellulose, microcrystalline cellulose (MCC), polyvinylpyrrolidone (PVP), starch. According to the research, the lactose segment had the largest share in the global excipients for oral solid dosage forms market. Furthermore, the coatings market has been categorized into sugar coating, film coating, others. The latest research indicates that the film coating segment occupied the largest share of this market in 2022 and is expected to draw the highest demand in coming years. The disintegrants market is further divided into croscarmellose sodium, crospovidone (cross linked PVP), sodium starch glycolate (SSG), others. Globally, the croscarmellose sodium segment made up the largest share of the excipients for oral solid dosage forms market.

The global excipients for oral solid dosage forms market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players ABITEC Corporation, Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Inc., BioSpectra Inc., Colorcon Inc., Croda International plc, DFE Pharma GmbH & Co KG., DuPont de Nemours Inc., Evonik Industries AG, JRS Pharma LP, MEGGLE GmbH & Co. KG, Merck & Co., Omya International AG, Roquette Freres SA, SPI Pharma (ABF Ingredients Ltd.), The Lubrizol Corporation.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
▹ Get a detailed picture of the Global Excipients for Oral Solid Dosage Forms Market
▹ Identify segments/areas to invest in over the forecast period in the Global Excipients for Oral Solid Dosage Forms Market
▹ Understand the competitive environment, the market’s leading players
▹ The market estimate for ease of analysis across scenarios in Excel format.
▹ Strategy consulting and research support for three months.
▹ Print authentication provided for the single-user license.